25 XP   0   0   10

Avecho Biotechnology Ltd
Buy, Hold or Sell?

Let's analyse Avecho together

PenkeI guess you are interested in Avecho Biotechnology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avecho Biotechnology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avecho Biotechnology Ltd

I send you an email if I find something interesting about Avecho Biotechnology Ltd.

Quick analysis of Avecho (30 sec.)










What can you expect buying and holding a share of Avecho? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
124.7%

For what price can you sell your share?

Current Price per Share
A$0.00
Expected price per share
A$0.004 - A$0.005
How sure are you?
50%

1. Valuation of Avecho (5 min.)




Live pricePrice per Share (EOD)

A$0.00

Intrinsic Value Per Share

A$-0.02 - A$0.00

Total Value Per Share

A$-0.01 - A$0.01

2. Growth of Avecho (5 min.)




Is Avecho growing?

Current yearPrevious yearGrowGrow %
How rich?$4m$1.5m$2.5m62.0%

How much money is Avecho making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$1.5m-$700.7k-31.8%
Net Profit Margin-725.7%-207.4%--

How much money comes from the company's main activities?

3. Financial Health of Avecho (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#777 / 1019

Most Revenue
#583 / 1019

Most Profit
#314 / 1019

Most Efficient
#787 / 1019

What can you expect buying and holding a share of Avecho? (5 min.)

Welcome investor! Avecho's management wants to use your money to grow the business. In return you get a share of Avecho.

What can you expect buying and holding a share of Avecho?

First you should know what it really means to hold a share of Avecho. And how you can make/lose money.

Speculation

The Price per Share of Avecho is A$0.004. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avecho.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avecho, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avecho.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-17.4%0.00-17.4%0.00-11.8%0.00-11.1%0.00-35.3%
Usd Book Value Change Per Share0.0020.0%0.0020.0%0.00-10.7%0.002.5%0.00-17.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.004.4%0.002.2%
Usd Total Gains Per Share0.0020.0%0.0020.0%0.00-10.7%0.006.9%0.00-15.2%
Usd Price Per Share0.00-0.00-0.01-0.01-0.01-
Price to Earnings Ratio-3.23--3.23--20.30--11.48--10.19-
Price-to-Total Gains Ratio2.81-2.81--22.51--8.21--3.67-
Price to Book Ratio1.74-1.74-19.60-13.82-9.61-
Price-to-Total Gains Ratio2.81-2.81--22.51--8.21--3.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0025616
Number of shares390381
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (390381 shares)311.81108.50
Gains per Year (390381 shares)1,247.24433.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1012471237278156424
2024942484555313858
30374237318334691292
404989497811106251726
506236622513887822160
607483747216669382594
7087318719194310953028
8099789966222112513462
901122511213249914073896
1001247212460277615644330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.09.00.010.0%5.026.00.016.1%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%14.016.01.045.2%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%5.00.026.016.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%15.016.00.048.4%

Fundamentals of Avecho

About Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health related products using its proprietary drug delivery system, Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Fundamental data was last updated by Penke on 2024-03-28 19:08:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avecho Biotechnology Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avecho earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Net Profit Margin of -725.7% means that $-7.26 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avecho Biotechnology Ltd:

  • The MRQ is -725.7%. The company is making a huge loss. -2
  • The TTM is -725.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-725.7%TTM-725.7%0.0%
TTM-725.7%YOY-207.4%-518.3%
TTM-725.7%5Y-407.9%-317.8%
5Y-407.9%10Y-554.5%+146.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-725.7%-197.2%-528.5%
TTM-725.7%-210.4%-515.3%
YOY-207.4%-279.3%+71.9%
5Y-407.9%-436.8%+28.9%
10Y-554.5%-599.3%+44.8%
1.1.2. Return on Assets

Shows how efficient Avecho is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • -47.0% Return on Assets means that Avecho generated $-0.47 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avecho Biotechnology Ltd:

  • The MRQ is -47.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -47.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-47.0%TTM-47.0%0.0%
TTM-47.0%YOY-70.0%+23.1%
TTM-47.0%5Y-50.7%+3.7%
5Y-50.7%10Y-65.3%+14.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-47.0%-13.6%-33.4%
TTM-47.0%-12.9%-34.1%
YOY-70.0%-11.9%-58.1%
5Y-50.7%-14.2%-36.5%
10Y-65.3%-16.2%-49.1%
1.1.3. Return on Equity

Shows how efficient Avecho is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • -53.9% Return on Equity means Avecho generated $-0.54 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avecho Biotechnology Ltd:

  • The MRQ is -53.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -53.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.9%TTM-53.9%0.0%
TTM-53.9%YOY-96.6%+42.7%
TTM-53.9%5Y-63.4%+9.5%
5Y-63.4%10Y-78.9%+15.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.9%-17.0%-36.9%
TTM-53.9%-16.1%-37.8%
YOY-96.6%-15.4%-81.2%
5Y-63.4%-20.0%-43.4%
10Y-78.9%-21.1%-57.8%

1.2. Operating Efficiency of Avecho Biotechnology Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avecho is operating .

  • Measures how much profit Avecho makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • An Operating Margin of -969.1% means the company generated $-9.69  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avecho Biotechnology Ltd:

  • The MRQ is -969.1%. The company is operating very inefficient. -2
  • The TTM is -969.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-969.1%TTM-969.1%0.0%
TTM-969.1%YOY-206.9%-762.2%
TTM-969.1%5Y-521.4%-447.7%
5Y-521.4%10Y-487.8%-33.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-969.1%-286.1%-683.0%
TTM-969.1%-224.4%-744.7%
YOY-206.9%-288.4%+81.5%
5Y-521.4%-475.2%-46.2%
10Y-487.8%-624.7%+136.9%
1.2.2. Operating Ratio

Measures how efficient Avecho is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.69 means that the operating costs are $10.69 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 10.691. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.691. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.691TTM10.6910.000
TTM10.691YOY3.713+6.978
TTM10.6915Y6.365+4.326
5Y6.36510Y6.982-0.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.6912.997+7.694
TTM10.6913.247+7.444
YOY3.7133.766-0.053
5Y6.3655.675+0.690
10Y6.9827.857-0.875

1.3. Liquidity of Avecho Biotechnology Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avecho is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.30 means the company has $8.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 8.305. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.305. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.305TTM8.3050.000
TTM8.305YOY3.825+4.480
TTM8.3055Y6.270+2.035
5Y6.27010Y6.988-0.718
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3053.930+4.375
TTM8.3054.251+4.054
YOY3.8255.436-1.611
5Y6.2706.045+0.225
10Y6.9886.363+0.625
1.3.2. Quick Ratio

Measures if Avecho is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Quick Ratio of 7.83 means the company can pay off $7.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 7.831. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.831. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.831TTM7.8310.000
TTM7.831YOY3.085+4.746
TTM7.8315Y5.681+2.150
5Y5.68110Y6.515-0.834
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8313.629+4.202
TTM7.8314.065+3.766
YOY3.0855.397-2.312
5Y5.6815.993-0.312
10Y6.5156.277+0.238

1.4. Solvency of Avecho Biotechnology Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avecho assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avecho to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Avecho assets are financed with 12.9% credit (debt) and the remaining percentage (100% - 12.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 0.129. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.129. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.1290.000
TTM0.129YOY0.275-0.147
TTM0.1295Y0.170-0.042
5Y0.17010Y0.149+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.332-0.203
TTM0.1290.334-0.205
YOY0.2750.268+0.007
5Y0.1700.366-0.196
10Y0.1490.390-0.241
1.4.2. Debt to Equity Ratio

Measures if Avecho is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avecho to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.8% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avecho Biotechnology Ltd:

  • The MRQ is 0.148. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.148. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.148TTM0.1480.000
TTM0.148YOY0.380-0.232
TTM0.1485Y0.213-0.065
5Y0.21310Y0.183+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1480.381-0.233
TTM0.1480.390-0.242
YOY0.3800.334+0.046
5Y0.2130.434-0.221
10Y0.1830.466-0.283

2. Market Valuation of Avecho Biotechnology Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avecho generates.

  • Above 15 is considered overpriced but always compare Avecho to the Biotechnology industry mean.
  • A PE ratio of -3.23 means the investor is paying $-3.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is -3.689. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.228. Based on the earnings, the company is expensive. -2
  • The TTM is -3.228. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.689MRQ-3.228-0.461
MRQ-3.228TTM-3.2280.000
TTM-3.228YOY-20.295+17.067
TTM-3.2285Y-11.481+8.253
5Y-11.48110Y-10.185-1.296
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.689-2.315-1.374
MRQ-3.228-2.560-0.668
TTM-3.228-2.664-0.564
YOY-20.295-4.122-16.173
5Y-11.481-6.258-5.223
10Y-10.185-6.108-4.077
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is -3.987. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.488. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.488. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.987MRQ-3.488-0.498
MRQ-3.488TTM-3.4880.000
TTM-3.488YOY-27.666+24.178
TTM-3.4885Y-19.848+16.359
5Y-19.84810Y-16.859-2.988
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.987-3.067-0.920
MRQ-3.488-3.251-0.237
TTM-3.488-3.545+0.057
YOY-27.666-5.595-22.071
5Y-19.848-8.315-11.533
10Y-16.859-8.708-8.151
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avecho is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.74 means the investor is paying $1.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avecho Biotechnology Ltd:

  • The EOD is 1.988. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.739. Based on the equity, the company is underpriced. +1
  • The TTM is 1.739. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.988MRQ1.739+0.248
MRQ1.739TTM1.7390.000
TTM1.739YOY19.605-17.866
TTM1.7395Y13.822-12.083
5Y13.82210Y9.614+4.209
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9881.905+0.083
MRQ1.7392.111-0.372
TTM1.7392.095-0.356
YOY19.6052.836+16.769
5Y13.8223.443+10.379
10Y9.6143.794+5.820
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avecho Biotechnology Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Avecho Biotechnology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0010.0010%-0.001+153%0.000+698%-0.001+187%
Book Value Per Share--0.0020.0020%0.001+163%0.001+54%0.004-47%
Current Ratio--8.3058.3050%3.825+117%6.270+32%6.988+19%
Debt To Asset Ratio--0.1290.1290%0.275-53%0.170-25%0.149-13%
Debt To Equity Ratio--0.1480.1480%0.380-61%0.213-31%0.183-19%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.001-0.0010%-0.001-32%-0.001-36%-0.002+103%
Free Cash Flow Per Share---0.001-0.0010%-0.001-46%-0.001-47%-0.001+23%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.001+145%0.000+527%0.000+2520%
Gross Profit Margin--1.0001.0000%1.025-2%1.171-15%1.086-8%
Intrinsic Value_10Y_max--0.003--------
Intrinsic Value_10Y_min---0.016--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max---0.001--------
Intrinsic Value_3Y_min---0.004--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min---0.007--------
Market Cap12677199.872+13%11092549.88811092549.8880%47539499.520-77%42151689.574-74%65129114.342-83%
Net Profit Margin---7.257-7.2570%-2.074-71%-4.079-44%-5.545-24%
Operating Margin---9.691-9.6910%-2.069-79%-5.214-46%-4.878-50%
Operating Ratio--10.69110.6910%3.713+188%6.365+68%6.982+53%
Pb Ratio1.988+13%1.7391.7390%19.605-91%13.822-87%9.614-82%
Pe Ratio-3.689-14%-3.228-3.2280%-20.295+529%-11.481+256%-10.185+216%
Price Per Share0.004+13%0.0040.0040%0.015-77%0.013-74%0.021-83%
Price To Free Cash Flow Ratio-3.987-14%-3.488-3.4880%-27.666+693%-19.848+469%-16.859+383%
Price To Total Gains Ratio3.207+13%2.8062.8060%-22.512+902%-8.211+393%-3.669+231%
Quick Ratio--7.8317.8310%3.085+154%5.681+38%6.515+20%
Return On Assets---0.470-0.4700%-0.700+49%-0.507+8%-0.653+39%
Return On Equity---0.539-0.5390%-0.966+79%-0.634+18%-0.789+46%
Total Gains Per Share--0.0010.0010%-0.001+153%0.000+187%-0.001+176%
Usd Book Value--4084323.9084084323.9080%1552903.398+163%2657996.466+54%7726989.232-47%
Usd Book Value Change Per Share--0.0010.0010%0.000+153%0.000+698%-0.001+187%
Usd Book Value Per Share--0.0010.0010%0.000+163%0.001+54%0.002-47%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.001-0.0010%0.000-32%0.000-36%-0.001+103%
Usd Free Cash Flow---2036443.182-2036443.1820%-1100419.172-46%-1080904.263-47%-2510735.269+23%
Usd Free Cash Flow Per Share---0.001-0.0010%0.000-46%0.000-47%-0.001+23%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%0.000+145%0.000+527%0.000+2520%
Usd Market Cap8118478.798+13%7103668.9487103668.9480%30444295.493-77%26993942.003-74%41708684.825-83%
Usd Price Per Share0.003+13%0.0020.0020%0.010-77%0.009-74%0.013-83%
Usd Profit---2200773.664-2200773.6640%-1500067.196-32%-1466506.650-33%-4505553.732+105%
Usd Revenue--303262.060303262.0600%723178.104-58%899012.860-66%976790.785-69%
Usd Total Gains Per Share--0.0010.0010%0.000+153%0.000+187%-0.001+176%
 EOD+6 -2MRQTTM+0 -0YOY+18 -165Y+18 -1810Y+21 -15

4.2. Fundamental Score

Let's check the fundamental score of Avecho Biotechnology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.689
Price to Book Ratio (EOD)Between0-11.988
Net Profit Margin (MRQ)Greater than0-7.257
Operating Margin (MRQ)Greater than0-9.691
Quick Ratio (MRQ)Greater than17.831
Current Ratio (MRQ)Greater than18.305
Debt to Asset Ratio (MRQ)Less than10.129
Debt to Equity Ratio (MRQ)Less than10.148
Return on Equity (MRQ)Greater than0.15-0.539
Return on Assets (MRQ)Greater than0.05-0.470
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Avecho Biotechnology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.439
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.004
OpenGreater thanClose0.004
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets7,319
Total Liabilities942
Total Stockholder Equity6,378
 As reported
Total Liabilities 942
Total Stockholder Equity+ 6,378
Total Assets = 7,319

Assets

Total Assets7,319
Total Current Assets7,004
Long-term Assets316
Total Current Assets
Cash And Cash Equivalents 5,504
Net Receivables 1,100
Inventory 97
Other Current Assets 303
Total Current Assets  (as reported)7,004
Total Current Assets  (calculated)7,004
+/-0
Long-term Assets
Property Plant Equipment 316
Long-term Assets Other 0
Long-term Assets  (as reported)316
Long-term Assets  (calculated)316
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities843
Long-term Liabilities98
Total Stockholder Equity6,378
Total Current Liabilities
Short-term Debt 77
Accounts payable 95
Other Current Liabilities 513
Total Current Liabilities  (as reported)843
Total Current Liabilities  (calculated)685
+/- 158
Long-term Liabilities
Long-term Liabilities  (as reported)98
Long-term Liabilities  (calculated)0
+/- 98
Total Stockholder Equity
Common Stock244,606
Retained Earnings -239,628
Accumulated Other Comprehensive Income 1,400
Total Stockholder Equity (as reported)6,378
Total Stockholder Equity (calculated)6,378
+/-0
Other
Cash and Short Term Investments 5,504
Common Stock Shares Outstanding 2,268,084
Current Deferred Revenue158
Liabilities and Stockholders Equity 7,319
Net Debt -5,329
Net Working Capital 6,160
Short Long Term Debt Total 175



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-31
> Total Assets 
11,875
11,193
34,482
0
5,522
1,620
5,096
20,860
18,397
14,839
29,408
114,034
171,072
173,494
171,521
69,189
67,364
53,768
76,577
64,121
42,958
50,901
30,744
13,354
8,240
4,802
5,315
3,355
5,246
3,346
7,319
7,3193,3465,2463,3555,3154,8028,24013,35430,74450,90142,95864,12176,57753,76867,36469,189171,521173,494171,072114,03429,40814,83918,39720,8605,0961,6205,522034,48211,19311,875
   > Total Current Assets 
11,875
1,749
111
0
17
281
2,277
4,665
3,559
2,250
2,424
7,934
14,648
16,026
12,371
13,510
11,547
3,724
30,759
23,117
14,155
27,056
17,956
10,183
5,802
3,247
4,278
2,691
4,808
2,851
7,004
7,0042,8514,8082,6914,2783,2475,80210,18317,95627,05614,15523,11730,7593,72411,54713,51012,37116,02614,6487,9342,4242,2503,5594,6652,2772811701111,74911,875
       Cash And Cash Equivalents 
147
296
81
183
1
153
2,236
4,232
3,284
2,196
2,312
7,222
13,189
14,425
10,715
12,896
10,868
2,740
27,196
16,912
8,823
20,679
12,395
6,092
2,899
2,111
3,211
1,873
3,265
1,468
5,504
5,5041,4683,2651,8733,2112,1112,8996,09212,39520,6798,82316,91227,1962,74010,86812,89610,71514,42513,1897,2222,3122,1963,2844,2322,236153118381296147
       Short-term Investments 
10,038
0
0
0
0
0
29
400
240
0
14
0
0
0
0
0
0
0
0
0
0
0
0
205
455
57
0
0
0
86
0
08600057455205000000000000140240400290000010,038
       Net Receivables 
1,674
1,453
30
189
13
128
12
33
35
31
66
660
1,003
1,498
1,577
232
292
305
2,376
4,993
4,421
5,213
4,724
3,607
2,395
677
755
479
1,127
746
1,100
1,1007461,1274797556772,3953,6074,7245,2134,4214,9932,3763052922321,5771,4981,003660663135331212813189301,4531,674
       Other Current Assets 
16
0
0
0
3
0
0
0
0
22
32
45
0
0
0
0
0
157
223
358
212
562
542
247
218
359
163
239
219
235
303
303235219239163359218247542562212358223157000004532220000300016
   > Long-term Assets 
0
9,444
34,371
0
5,505
1,339
2,819
16,195
14,838
12,589
26,985
106,099
156,424
157,468
159,150
55,679
55,817
50,044
45,818
41,004
28,803
23,845
12,788
3,171
2,437
1,555
1,037
664
438
494
316
3164944386641,0371,5552,4373,17112,78823,84528,80341,00445,81850,04455,81755,679159,150157,468156,424106,09926,98512,58914,83816,1952,8191,3395,505034,3719,4440
       Property Plant Equipment 
0
0
0
0
0
0
19
167
143
120
96
280
611
1,023
1,902
3,617
3,755
2,767
2,563
2,370
2,196
814
519
385
251
160
180
233
336
468
316
3164683362331801602513855198142,1962,3702,5632,7673,7553,6171,9021,0236112809612014316719000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
34,261
34,261
34,261
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000034,26134,26134,261000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
105,820
121,552
122,184
122,987
52,062
52,062
45,577
43,255
38,634
26,607
23,031
12,269
2,786
2,186
1,395
857
431
102
26
0
0261024318571,3952,1862,78612,26923,03126,60738,63443,25545,57752,06252,062122,987122,184121,552105,82000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000
> Total Liabilities 
1,459
380
5,579
0
73
33
72
185
56
30
25
811
38,935
38,020
37,759
17,636
17,375
14,761
3,631
1,509
2,187
1,873
1,816
1,707
1,836
902
556
700
709
921
942
9429217097005569021,8361,7071,8161,8732,1871,5093,63114,76117,37517,63637,75938,02038,93581125305618572337305,5793801,459
   > Total Current Liabilities 
763
92
2,168
0
73
33
72
185
56
30
25
811
38,935
1,102
841
1,508
1,247
931
3,602
1,453
2,120
1,778
1,781
1,663
1,714
873
545
604
696
746
843
8437466966045458731,7141,6631,7811,7782,1201,4533,6029311,2471,5088411,10238,93581125305618572337302,16892763
       Short-term Debt 
10,038
0
0
0
0
0
29
400
240
0
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
73
80
71
77
7771807389000000000000000140240400290000010,038
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
409
572
1,080
132
97
110
75
191
95
9519175110971321,0805724090000000000000000000000
       Other Current Liabilities 
-9,275
92
2,168
11
73
33
35
-277
-201
0
0
0
356
0
0
0
0
0
0
0
0
0
261
221
525
740
359
420
540
483
513
513483540420359740525221261000000000356000-201-277353373112,16892-9,275
   > Long-term Liabilities 
696
288
3,411
0
0
0
0
0
0
0
0
0
0
36,918
36,918
16,128
16,128
13,830
29
56
67
95
35
44
123
30
11
97
14
175
98
981751497113012344359567562913,83016,12816,12836,91836,91800000000003,411288696
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
93
14
175
0
01751493800000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
44
123
30
4
3
0
0
0
000343012344350000000000000000000000
> Total Stockholder Equity
10,416
10,813
28,903
0
5,449
1,587
5,024
20,675
18,341
14,808
29,383
113,223
132,184
135,474
133,762
51,553
49,989
39,007
72,946
62,612
40,771
49,028
28,928
11,647
6,403
3,900
4,759
2,654
4,537
2,425
6,378
6,3782,4254,5372,6544,7593,9006,40311,64728,92849,02840,77162,61272,94639,00749,98951,553133,762135,474132,184113,22329,38314,80818,34120,6755,0241,5875,449028,90310,81310,416
   Common Stock
10,000
11,228
11,926
12,780
13,167
14,174
17,107
33,932
33,934
34,750
39,701
134,731
145,306
154,608
161,544
170,316
176,905
176,905
209,546
209,861
209,895
228,100
228,100
228,100
231,274
232,632
232,632
232,778
237,602
237,529
244,606
244,606237,529237,602232,778232,632232,632231,274228,100228,100228,100209,895209,861209,546176,905176,905170,316161,544154,608145,306134,73139,70134,75033,93433,93217,10714,17413,16712,78011,92611,22810,000
   Retained Earnings 
416
-570
-5,143
-7,974
-8,725
-12,586
-12,083
-13,257
-18,623
-22,971
-25,633
-25,751
-41,028
-47,154
-56,042
-147,248
-155,749
-167,024
-165,918
-176,973
-199,038
-209,243
-229,363
-246,677
-255,222
-259,149
-256,026
-230,848
-234,254
-264,104
-239,628
-239,628-264,104-234,254-230,848-256,026-259,149-255,222-246,677-229,363-209,243-199,038-176,973-165,918-167,024-155,749-147,248-56,042-47,154-41,028-25,751-25,633-22,971-18,623-13,257-12,083-12,586-8,725-7,974-5,143-570416
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
0
155
22,120
0
1,007
0
2
13
3,077
0
0
0
0
0
0
0
0
0
0
0
0
0
30,191
30,224
30,352
30,416
28,153
28,537
29,002
25
0
02529,00228,53728,15330,41630,35230,22430,19100000000000003,07713201,007022,1201550



Balance Sheet

All numbers in thousands.